Sernova Corp
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Bio… Read more
Market Cap & Net Worth: Sernova Corp (SEOVF)
Sernova Corp (OTCQB:SEOVF) has a market capitalization of $43.13 Million ($43.13 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #22997 globally and #8077 in its home market, demonstrating a 16.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sernova Corp's stock price $0.13 by its total outstanding shares 336698561 (336.70 Million).
Sernova Corp Market Cap History: 2015 to 2025
Sernova Corp's market capitalization history from 2015 to 2025. Data shows change from $73.40 Million to $43.13 Million (-6.29% CAGR).
Sernova Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sernova Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SEOVF by Market Capitalization
Companies near Sernova Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Sernova Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Sernova Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Sernova Corp's market cap moved from $73.40 Million to $ 43.13 Million, with a yearly change of -6.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $43.13 Million | -24.65% |
| 2024 | $57.24 Million | -67.92% |
| 2023 | $178.45 Million | -10.17% |
| 2022 | $198.65 Million | -59.31% |
| 2021 | $488.21 Million | +173.58% |
| 2020 | $178.45 Million | +300.00% |
| 2019 | $44.61 Million | -11.19% |
| 2018 | $50.24 Million | -56.09% |
| 2017 | $114.41 Million | +67.80% |
| 2016 | $68.18 Million | -7.11% |
| 2015 | $73.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sernova Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.13 Million USD |
| MoneyControl | $43.13 Million USD |
| MarketWatch | $43.13 Million USD |
| marketcap.company | $43.13 Million USD |
| Reuters | $43.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.